Literature DB >> 15200413

Decreased expression of T-cell NF-kappaB p65 subunit in steroid-resistant nephrotic syndrome.

Diego H Aviles1, V Matti Vehaskari, Jennifer Manning, Augusto C Ochoa, Arnold H Zea.   

Abstract

BACKGROUND: Although the etiology of childhood nephrotic syndrome is unclear, there is evidence to suggest an important role for T cells in the pathogenesis. Steroid resistance is considered a poor prognostic sign but the mechanism of the resistance is unknown. The study examined the potential role of T-cell nuclear transcription factors in the steroid resistance.
METHODS: The expression of the nuclear transcription factors activating protein-1 (AP-1) and nuclear factor-kappaB (NF-kappaB) as well as that of lymphokines interleukin (IL)-2, IL-4, and interferon-gamma (IFN-gamma) were compared in T cells obtained from normal subjects, children with steroid-sensitive nephrotic syndrome (SSNS) and children with steroid-resistant nephrotic syndrome (SRNS) before any treatment was given. Changes in expression and binding of the nuclear transcription factors were studied with electrophoretic mobility shift assay (EMSA) and Western blot, whereas mRNA cytokine expression were evaluated by enzyme-linked immunosorbent assay (ELISA)-linked reverse transcription-polymerase chain reaction (RT-PCR).
RESULTS: A significant decrease of the p65 subunit protein of NF-kappaB but not in p50 was documented by both EMSA (N= 7) and Western blotting (N= 5) in five of five SRNS patients but not in control subjects or SSNS patients; there was a decrease in mRNA expression as shown by ELISA-linked RT-PCR. In contrast, there were no significant differences in AP-1 expression by EMSA. IL-2 mRNA level was higher in T cells from SRNS patients than in T cells from either SSNS or control subjects. IL-4 and IFN-gamma were equally decreased in both groups of patients.
CONCLUSION: The results show differences in T cells between untreated SSNS and SRNS patients. The decrease of NF-kappaB p65 subunit and up-regulation of IL-2 are potential mechanism of glucocorticoid resistance in SRNS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15200413     DOI: 10.1111/j.1523-1755.2004.00706.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  8 in total

Review 1.  Minimal change disease and idiopathic FSGS: manifestations of the same disease.

Authors:  Rutger J Maas; Jeroen K Deegens; Bart Smeets; Marcus J Moeller; Jack F Wetzels
Journal:  Nat Rev Nephrol       Date:  2016-10-17       Impact factor: 28.314

2.  Low expression of glucocorticoid receptors in children with steroid-resistant nephrotic syndrome.

Authors:  Ayman Hammad; Sohier Yahia; Mona Samy Gouida; Ashraf Bakr; Reham M El-farahaty
Journal:  Pediatr Nephrol       Date:  2013-01-09       Impact factor: 3.714

Review 3.  Klotho: A Possible Role in the Pathophysiology of Nephrotic Syndrome.

Authors:  Sojit Tomo; Amandeep Birdi; Dharmveer Yadav; Manish Chaturvedi; Praveen Sharma
Journal:  EJIFCC       Date:  2022-04-11

4.  T cell CD3 receptor zeta (TCRzeta)-chain expression in children with idiopathic nephrotic syndrome.

Authors:  Diego H Aviles; Matti V Vehaskari; Kirk S Culotta; Jennifer Manning; Augusto C Ochoa; Arnold H Zea
Journal:  Pediatr Nephrol       Date:  2008-12-10       Impact factor: 3.714

5.  Remission of refractory minimal change nephrotic syndrome after basiliximab therapy.

Authors:  Sung-Shin Park; Won-Ho Hahn; Sung-Do Kim; Byoung-Soo Cho
Journal:  Pediatr Nephrol       Date:  2009-02-26       Impact factor: 3.714

Review 6.  The Role of Cytokines in Nephrotic Syndrome.

Authors:  Elham Ahmadian; Yalda Rahbar Saadat; Elaheh Dalir Abdolahinia; Milad Bastami; Mohammadali M Shoja; Sepideh Zununi Vahed; Mohammadreza Ardalan
Journal:  Mediators Inflamm       Date:  2022-02-09       Impact factor: 4.711

7.  Gene Expression as a Guide to the Development of Novel Therapies in Primary Glomerular Diseases.

Authors:  Panagiotis Garantziotis; Stavros A P Doumas; Ioannis Boletis; Eleni Frangou
Journal:  J Clin Med       Date:  2021-05-24       Impact factor: 4.241

8.  Activation of the IL-2 Receptor in Podocytes: A Potential Mechanism for Podocyte Injury in Idiopathic Nephrotic Syndrome?

Authors:  Arnold H Zea; Tyrus Stewart; Jeannine Ascani; David J Tate; Beatriz Finkel-Jimenez; Anna Wilk; Krzysztof Reiss; William E Smoyer; Diego H Aviles
Journal:  PLoS One       Date:  2016-07-07       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.